NO905038L - Fremgangsmaate for fremstilling av nye peptider. - Google Patents
Fremgangsmaate for fremstilling av nye peptider.Info
- Publication number
- NO905038L NO905038L NO90905038A NO905038A NO905038L NO 905038 L NO905038 L NO 905038L NO 90905038 A NO90905038 A NO 90905038A NO 905038 A NO905038 A NO 905038A NO 905038 L NO905038 L NO 905038L
- Authority
- NO
- Norway
- Prior art keywords
- grp
- bombesin
- derivatives
- gastric
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102100036519 Gastrin-releasing peptide Human genes 0.000 abstract 8
- 108010051479 Bombesin Proteins 0.000 abstract 4
- DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 abstract 4
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000010256 biochemical assay Methods 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000012875 competitive assay Methods 0.000 abstract 1
- 230000009137 competitive binding Effects 0.000 abstract 1
- 230000002183 duodenal effect Effects 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001175 peptic effect Effects 0.000 abstract 1
- 208000000587 small cell lung carcinoma Diseases 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57572—Gastrin releasing peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44054789A | 1989-11-22 | 1989-11-22 | |
| US60383090A | 1990-10-31 | 1990-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO905038D0 NO905038D0 (no) | 1990-11-21 |
| NO905038L true NO905038L (no) | 1991-05-23 |
Family
ID=27032451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90905038A NO905038L (no) | 1989-11-22 | 1990-11-21 | Fremgangsmaate for fremstilling av nye peptider. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0434979B1 (de) |
| JP (1) | JP2927936B2 (de) |
| KR (1) | KR910009730A (de) |
| CN (1) | CN1051914A (de) |
| AT (1) | ATE132501T1 (de) |
| AU (1) | AU638775B2 (de) |
| CA (1) | CA2030212A1 (de) |
| DE (1) | DE69024626T2 (de) |
| ES (1) | ES2084635T3 (de) |
| FI (1) | FI905741A7 (de) |
| HU (1) | HUT55798A (de) |
| IE (1) | IE904211A1 (de) |
| IL (1) | IL96402A0 (de) |
| NO (1) | NO905038L (de) |
| NZ (1) | NZ236114A (de) |
| PT (1) | PT95953A (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5723578A (en) * | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
| US5877277A (en) | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
| US5834433A (en) * | 1990-07-26 | 1998-11-10 | Merrell Pharmaceuticals Inc. | Compounds and pharmaceutical uses of peptides of bombesin and GRP |
| DK0585397T3 (da) * | 1991-05-23 | 1997-08-25 | Merrell Pharma Inc | Bombesinanaloger |
| HUT71585A (en) * | 1992-02-07 | 1995-12-28 | Merrell Dow Pharma | Process for producing bombesin phenylalanine analogue peptides |
| US5410018A (en) * | 1994-02-25 | 1995-04-25 | Oregon Regional Primate Research Center | Bombesin-related peptides |
| TR200100916T2 (de) * | 1998-07-14 | 2002-06-21 | Corixa@@Corporation | |
| US8709998B2 (en) | 2003-04-22 | 2014-04-29 | Ipsen Pharma S.A.S. | Peptide vectors |
| CN100372869C (zh) * | 2006-04-18 | 2008-03-05 | 河北师范大学 | 棕点湍蛙抗微生物多肽及其在制药中的应用 |
| CN101445554B (zh) * | 2008-12-26 | 2012-06-27 | 辽宁师范大学 | 林蛙抗癌肽及其制备方法 |
| CN110133300B (zh) * | 2012-03-18 | 2022-02-25 | 镜株式会社 | 疾病样品分析装置、分析系统及分析方法 |
| CN119104644B (zh) * | 2024-09-09 | 2025-09-02 | 江苏省食品药品监督检验研究院(江苏省食品质量安全监控中心) | 一种氨基酸分析仪测定海藻碘盐中有机碘的分析方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989002897A1 (en) * | 1987-09-24 | 1989-04-06 | The Administrators Of The Tulane Educational Fund | Therapeutic peptides |
-
1990
- 1990-11-16 CA CA002030212A patent/CA2030212A1/en not_active Abandoned
- 1990-11-16 NZ NZ236114A patent/NZ236114A/xx unknown
- 1990-11-19 IL IL96402A patent/IL96402A0/xx unknown
- 1990-11-21 IE IE421190A patent/IE904211A1/en unknown
- 1990-11-21 JP JP2314457A patent/JP2927936B2/ja not_active Expired - Fee Related
- 1990-11-21 NO NO90905038A patent/NO905038L/no unknown
- 1990-11-21 HU HU907234A patent/HUT55798A/hu unknown
- 1990-11-21 PT PT95953A patent/PT95953A/pt not_active Application Discontinuation
- 1990-11-21 AU AU66793/90A patent/AU638775B2/en not_active Ceased
- 1990-11-21 FI FI905741A patent/FI905741A7/fi not_active Application Discontinuation
- 1990-11-22 EP EP90122330A patent/EP0434979B1/de not_active Expired - Lifetime
- 1990-11-22 ES ES90122330T patent/ES2084635T3/es not_active Expired - Lifetime
- 1990-11-22 DE DE69024626T patent/DE69024626T2/de not_active Expired - Fee Related
- 1990-11-22 AT AT90122330T patent/ATE132501T1/de not_active IP Right Cessation
- 1990-11-22 CN CN90109352A patent/CN1051914A/zh active Pending
- 1990-11-22 KR KR1019900018934A patent/KR910009730A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IE904211A1 (en) | 1991-05-22 |
| AU638775B2 (en) | 1993-07-08 |
| EP0434979B1 (de) | 1996-01-03 |
| EP0434979A1 (de) | 1991-07-03 |
| CN1051914A (zh) | 1991-06-05 |
| HU907234D0 (en) | 1991-05-28 |
| DE69024626D1 (de) | 1996-02-15 |
| PT95953A (pt) | 1991-09-13 |
| ES2084635T3 (es) | 1996-05-16 |
| IL96402A0 (en) | 1991-08-16 |
| JP2927936B2 (ja) | 1999-07-28 |
| NZ236114A (en) | 1993-04-28 |
| ATE132501T1 (de) | 1996-01-15 |
| JPH03261800A (ja) | 1991-11-21 |
| AU6679390A (en) | 1991-05-30 |
| DE69024626T2 (de) | 1996-05-15 |
| FI905741L (fi) | 1991-05-23 |
| HUT55798A (en) | 1991-06-28 |
| CA2030212A1 (en) | 1991-05-23 |
| NO905038D0 (no) | 1990-11-21 |
| FI905741A7 (fi) | 1991-05-23 |
| KR910009730A (ko) | 1991-06-28 |
| FI905741A0 (fi) | 1990-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU638775B2 (en) | Antimitotic and antisecretary peptides that are antagonistic to the peptides bombesin and gastric releasing peptide | |
| Gregory | The Bayliss-Starling lecture 1973. The gastrointestinal hormones: a review of recent advances | |
| ATE124997T1 (de) | Enzymatische entfernung einer aminoterminalen proteinsequenz. | |
| NO882472D0 (no) | Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser. | |
| EP0403158A3 (de) | Imidazolyl-Alkensäuren | |
| AU641789B2 (en) | Peptides | |
| NO903944D0 (no) | Fremgangsmaate for fremstilling av nye peptidase og isomerase-inhibitorer. | |
| ATE125820T1 (de) | Verfahren und zusammensetzungen zur heilung von geschwüren. | |
| EP0303465A3 (de) | Phenethanolamin-Derivate | |
| NO177597C (no) | Analogifremgangsmåte for fremstilling av et terapeutisk aktivt peptid med bradykinin-antagonistisk virkning | |
| DE69221486D1 (de) | Bombesinanaloge | |
| AU6092490A (en) | Peptides having bradykinin antagonist action | |
| DE69002950D1 (de) | Peptide mit diaminoglycolen als übergangszustandmimik. | |
| EP0266993A3 (en) | Method and therapeutic compositions for the treatment of bleeding disorders | |
| EP0404055B1 (de) | Ghilanten: antimetastatischer Wirkstoff aus dem südamerikanischen Blutegel Haementeria Ghilianii | |
| EP0102026A3 (de) | Thiazolderivate | |
| WO1990012804A3 (en) | Peptides having novel polar n-terminal groups | |
| NO963255L (no) | Sykliske neurokinin-A antagonister | |
| EP0202084A3 (de) | Fluoralkanderivate | |
| WO1989010917A3 (en) | Renin inhibitors, process for producing them and use thereof | |
| Dudin et al. | THE MODIFIED METHOD OF STOMACH RESECTION | |
| EP0266006A3 (de) | Blutdrucksenkende, diuretische Peptide | |
| NO924701L (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer | |
| JPS56164152A (en) | Novel desacylpepsidin derivative and its preparation |